Patients should be informed about effects of placebos
- Details
- Category: Research
Research carried out at the University of Southampton has concluded that participants in drug trials should be better informed about the potential significant benefits and possible side-effects of placebos. Placebos are traditionally thought of as 'inert' pills, given in trials to act as a yardstick or constant by which to measure the effects of new 'active' drugs, known in clinical trials as the 'target treatment'.
New compound holds promise for treating Duchenne MD
- Details
- Category: Research
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.
Metformin may lower cancer risk in people with Type 2 diabetes
- Details
- Category: Research
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results have been presented at The Endocrine Society's 94th Annual Meeting in Houston.
Common blood pressure drug linked to severe GI problems
- Details
- Category: Research
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities - symptoms common among those who have celiac disease. The findings are published online in the medical journal Mayo Clinic Proceedings.
Computer model successfully predicts drug side effects
- Details
- Category: Research
A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according to a paper published in the journal Nature.
New report estimates nearly 18 million cancer survivors in the US by 2022
- Details
- Category: Research
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National Cancer Institute (NCI).
The challenges and opportunities of clinical trials in developing countries
- Details
- Category: Research
Conducting more clinical trials in developing countries is of benefit because these populations are underrepresented in research, but doing trials in resource poor settings has many challenges. Research sites in developing countries benefit from working with externally sponsored clinical trials including increased capacity development and investment, but locally led research is also challenged by complex trial regulations and administrative burdens.
More Pharma News ...
- Statins shown to cause fatigue
- Researchers develop a 'time bomb' to fight cardiovascular disease
- Alzheimer's vaccine trial a success
- New immune therapy shows promise in kidney cancer
- Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma
- New research yields insights into Parkinson's disease
- Thioridazine, successfully kills cancer stem cells in the human